Monthly Archives: February 2018
Neurotoxicity Characterized After Infusion of CD19 CAR-T Cells
October 12, 2017 (HealthDay News)
Patients with severe neurotoxicity after infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells have evidence of endothelial activation,...
Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma
Published on February 13, 2018
Sattva S. Neelapu, MD, discusses the safety and practical implications for axi-cel (KTE-C19) as part of the ZUMA-1 trial, as...
Omaha Firefighter Receives CAR T-Cell Therapy – Nebraska Medicine
Diagnosed with lymphoma, Nick Howe was out of options before he tried CAR T-Cell therapy at Nebraska Medicine. Today, the Omaha firefighter is in...
Tisagenlecleucel Beneficial for Youth With Refractory B-Cell ALL
January 31, 2018 (HealthDay News)
Single infusion provided durable remission with long-term persistence in pediatric, young adult patients
A single infusion of the anti-CD19...
Other Studies on CAR T-Cell Therapy
Here are some links to studies that have recently come out on CAR T-Cell. These are obtainable only by a paid subscription to the...
